Frances Boxall

4.4k total citations · 2 hit papers
21 papers, 3.1k citations indexed

About

Frances Boxall is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Frances Boxall has authored 21 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 7 papers in Hematology. Recurrent topics in Frances Boxall's work include Metal complexes synthesis and properties (9 papers), Chemotherapy-induced organ toxicity mitigation (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Frances Boxall is often cited by papers focused on Metal complexes synthesis and properties (9 papers), Chemotherapy-induced organ toxicity mitigation (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Frances Boxall collaborates with scholars based in United Kingdom, Spain and United States. Frances Boxall's co-authors include Zahid H. Siddik, David R. Newell, A. Hilary Calvert, Martin Gore, Lindsey Gumbrell, Ian Judson, E. Wiltshaw, Séamus O’Reilly, Matthew Burnell and Kenneth R. Harrap and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Biochemistry and British Journal of Cancer.

In The Last Decade

Frances Boxall

21 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

1989 1.5k citations A. Hilary Calvert, David R. Newell et al. Journal of Clinical Oncology profile →
Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation

2012 783 citations Maria Vinci, Sharon Gowan et al. BMC Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frances Boxall United Kingdom	15	1.6k	793	626	538	480	21	3.1k
J Cassidy United Kingdom	33	1.7k 1.0×	1.2k 1.5×	440 0.7×	594 1.1×	332 0.7×	79	4.5k
David A. Van Echo United States	26	1.5k 0.9×	916 1.2×	373 0.6×	437 0.8×	202 0.4×	71	3.0k
Pierre Canal France	34	1.9k 1.2×	1.3k 1.7×	506 0.8×	376 0.7×	174 0.4×	138	3.4k
Renzo Canetta United States	30	2.2k 1.3×	894 1.1×	751 1.2×	502 0.9×	107 0.2×	61	3.9k
M.B. Khazaeli United States	36	1.4k 0.8×	1.6k 2.0×	403 0.6×	521 1.0×	176 0.4×	90	4.4k
James L. Speyer United States	37	2.2k 1.4×	928 1.2×	473 0.8×	788 1.5×	114 0.2×	94	4.4k
Marcel Rozencweig Belgium	30	1.9k 1.2×	998 1.3×	598 1.0×	695 1.3×	90 0.2×	151	4.0k
R B Weiss United States	20	1.1k 0.6×	628 0.8×	185 0.3×	465 0.9×	127 0.3×	37	2.5k
Paula M. Fracasso United States	31	1.6k 1.0×	1.0k 1.3×	202 0.3×	477 0.9×	95 0.2×	109	3.0k
Christian Dittrich Austria	33	1.6k 1.0×	1.4k 1.8×	299 0.5×	833 1.5×	240 0.5×	136	4.0k

Countries citing papers authored by Frances Boxall

Since Specialization

Citations

This map shows the geographic impact of Frances Boxall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances Boxall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances Boxall more than expected).

Fields of papers citing papers by Frances Boxall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances Boxall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances Boxall. The network helps show where Frances Boxall may publish in the future.

Co-authorship network of co-authors of Frances Boxall

This figure shows the co-authorship network connecting the top 25 collaborators of Frances Boxall. A scholar is included among the top collaborators of Frances Boxall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frances Boxall. Frances Boxall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Calvert, A. Hilary, David R. Newell, Lindsey Gumbrell, et al.. (2023). Carboplatin dosage: prospective evaluation of a simple formula based on renal function.. Journal of Clinical Oncology. 41(28). 4453–4454. 5 indexed citations

2.

Vinci, Maria, Sharon Gowan, Frances Boxall, et al.. (2012). Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biology. 10(1). 29–29. 783 indexed citations breakdown →

3.

Pérez, Jose M., Lloyd R. Kèlland, Eva I. Montero, et al.. (2003). Antitumor and Cellular Pharmacological Properties of a Novel Platinum(IV) Complex:trans-[PtCl2(OH)2(Dimethylamine) (Isopropylamine)]. Molecular Pharmacology. 63(4). 933–944. 55 indexed citations

4.

Rogers, Paul, et al.. (2002). Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. European Journal of Cancer. 38(12). 1653–1660. 19 indexed citations

5.

Rogers, Paul, Philip Beale, Mansour Al‐Moundhri, et al.. (2001). Overexpression of Bcl_XL in a human ovarian carcinoma cell line: Paradoxic effects on chemosensitivity in vitro versus in vivo. International Journal of Cancer. 97(6). 858–863. 10 indexed citations

6.

Fulbrook, Paul, Gary Rolfe, John Albarran, & Frances Boxall. (2000). Fit for practice: Project 2000 student nurses’ views on how well the curriculum prepares them for clinical practice. Nurse Education Today. 20(5). 350–357. 13 indexed citations

7.

Beale, Philip, et al.. (2000). Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines. European Journal of Cancer. 36(15). 1984–1990. 61 indexed citations

8.

Beale, Philip, Paul Rogers, Frances Boxall, Swee Y. Sharp, & LR Kelland. (2000). BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma. British Journal of Cancer. 82(2). 436–440. 93 indexed citations

9.

Raynaud, Florence I., Frances Boxall, Phyllis M. Goddard, et al.. (1997). cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.. PubMed. 3(11). 2063–74. 106 indexed citations

10.

Raynaud, Florence I., Frances Boxall, Phyllis M. Goddard, et al.. (1996). Metabolism, protein binding and in vivo activity of the oral platinum drug JM216 and its biotransformation products.. PubMed. 16(4A). 1857–62. 33 indexed citations

11.

McKeage, Mark J., Prakash Mistry, Janet Ward, et al.. (1995). A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration. Cancer Chemotherapy and Pharmacology. 36(6). 451–458. 84 indexed citations

12.

McKeage, Mark J., Prakash Mistry, Janet Ward, et al.. (1995). A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration. Cancer Chemotherapy and Pharmacology. 36(6). 451–458. 2 indexed citations

13.

Kerr, Rachel, Craig Lewis, B. O'Neil, et al.. (1990). The myelotoxicity of carboplatin is influenced by the time of its administration. Hematological Oncology. 8(1). 59–63. 21 indexed citations

14.

Calvert, A. Hilary, David R. Newell, Lindsey Gumbrell, et al.. (1989). Carboplatin dosage: prospective evaluation of a simple formula based on renal function.. Journal of Clinical Oncology. 7(11). 1748–1756. 1510 indexed citations breakdown →

15.

Newell, David R., Zahid H. Siddik, Lindsey Gumbrell, et al.. (1987). Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin. European Journal of Cancer and Clinical Oncology. 23(9). 1399–1405. 64 indexed citations

16.

Siddik, Zahid H., et al.. (1987). The effect of diethyldithiocarbamate on the haematological toxicity and antitumour activity of carboplatin. European Journal of Cancer and Clinical Oncology. 23(6). 813–818. 15 indexed citations

17.

Siddik, Zahid H., Frances Boxall, & Kenneth R. Harrap. (1987). Flameless atomic absorption spectrophotometric determination of platinum in tissues solubilized in hyamine hydroxide. Analytical Biochemistry. 163(1). 21–26. 111 indexed citations

18.

Siddik, Zahid H., David R. Newell, Frances Boxall, & Kenneth R. Harrap. (1987). The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats. Biochemical Pharmacology. 36(12). 1925–1932. 113 indexed citations

19.

Siddik, Zahid H., Frances Boxall, A. Hilary Calvert, & Kenneth R. Harrap. (1985). Use of a solubilisation procedure in the determination of platinum (Pt) in rodent and human tissues following carboplatin (JM8, CBDCA) administration. Proceedings of the American Association for Cancer Research. 26. 1 indexed citations

20.

Siddik, Zahid H., David R. Newell, Mark Jones, & Frances Boxall. (1982). Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA, JM8) in mice and rats. Proceedings of the American Association for Cancer Research. 23. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact